A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example
A European legislation was put in place for the reporting of medication errors, and guidelines were drafted to help stakeholders in the reporting, evaluation, and, ultimately, minimization of these errors. As part of pharmacovigilance reporting, a proper classification of medication errors is needed...
Saved in:
Main Authors: | Christophe Dessart (Author), Fernanda Tavares- (Author), Lionel Van Holle (Author), Olivia Mahaux (Author), Jens-Ulrich Stegmann (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence
by: Raunak Parikh, et al.
Published: (2023) -
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
by: Nicolas Lecrenier, et al.
Published: (2018) -
Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview
by: Alemnew F. Dagnew, et al.
Published: (2021) -
Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
by: Makoto Shiragami, et al.
Published: (2019) -
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
by: Desmond Curran, et al.
Published: (2019)